Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Payment of exercise | Dispose F | No | No | 6.64 | 2,316 | 15.38 k | 73,220 |
2 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 7,775 | 0.00 | 75,536 |
2 Feb 25 | ALT Altimmune | RSU Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 7,775 | 0.00 | 7,775 |
1 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Payment of exercise | Dispose F | No | No | 6.64 | 1,801 | 11.96 k | 67,761 |
1 Feb 25 | ALT Altimmune | Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 6,166 | 0.00 | 69,562 |
1 Feb 25 | ALT Altimmune | RSU Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 6,166 | 0.00 | 0 |
31 Jan 25 | ALT Altimmune | Common Stock, par value $0.0001 | Grant | Acquire A | No | No | 5.18 | 3,184 | 16.49 k | 63,396 |
30 Jan 25 | ALT Altimmune | Common Stock, par value $0.0001 | Payment of exercise | Dispose F | No | No | 7 | 2,709 | 18.96 k | 60,212 |
30 Jan 25 | ALT Altimmune | Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 9,275 | 0.00 | 62,921 |
30 Jan 25 | ALT Altimmune | RSU Common Stock, par value $0.0001 | Option exercise | Acquire M | No | No | 0 | 9,275 | 0.00 | 18,550 |